Clinical Trial Update: Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating sunitinib as maintenance therapy for stage III or IV non-small cell lung cancer. The snippet provides no current status or res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Third Military Medical University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN